Studies Conducted at Universitas Negeri Gorontalo on Stroke Recently Published (The role of clinical reminder system to drug prescribing on patients of the National Health Insurance with ischemic stroke): Cerebrovascular Diseases and Conditions – Stroke

2023 JUN 01 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily -- New study results on stroke have been published. According to news reporting originating from the Universitas Negeri Gorontalo by NewsRx correspondents, research stated, “Since 2014 Indonesia has entered the era of universal health coverage (UHC) and public health financing system managed by the Social Security Organizing Agency Law/SSOAL (Badan Penyelenggara Jaminan Sosial/BPJS). In this system, a national formulary was used as the basis for prescribing drugs by clinicians.”

The news correspondents obtained a quote from the research from Universitas Negeri Gorontalo: “One effort for quality and cost control in UHC was to develop a clinical reminder system (CRS) to help prescriber set treatment options in accordance with the national formulary. The aim of this study was to measure the role of CRS to the compatibility of drug prescribing in patients with ischemic stroke in Bethesda Hospital Yogyakarta, Indonesia. This study was carried out using quasi-experimental with pre-test and post-test design. The subjects of this study were outpatient ischemic stroke and the National Health Insurance (NHI) participant, age >18 years and had complete medication data. Prescribing data were compared between stroke patients treated at the hospital before and after implementation of CRS. The study was performed in 200 National Health Insurance (NHI) scheme outpatients with ischemic stroke. The groups consisted of 100 patients without CRS and 100 patients with CRS. The basic characteristics of both groups were similar. The results showed that after implementation of CRS, a significant improvement in the compliance of the neurologist prescribing medicine used to be available only in national formulary (RR: 1.02; 95% CI=1.00-1.04; p=0.015).”

According to the news reporters, the research concluded: “Among others the most significant improvement was the prescription of antidyslipidemic using HMG-CoA medicine available in formulary. In conclusion, CRS can improve the compliance of prescribing with national formulary in stroke ischemic patients.”

For more information on this research see: The role of clinical reminder system to drug prescribing on patients of the National Health Insurance with ischemic stroke. Journal of the Medical Sciences, 2022,54(2). (Journal of the Medical Sciences - http://jurnal.ugm.ac.id/bik/index). The publisher for Journal of the Medical Sciences is Universitas Gadjah Mada.

A free version of this journal article is available at https://doi.org/10.19106/JMedSci005402202204.

Our news editors report that more information may be obtained by contacting Faramita Hiola, Faculty of Sports and Health, Universitas Negeri Gorontalo, Gorontalo, Indonesia. Additional authors for this research include Iwan Dwiprahasto, Rizaldy Pinzon.

(Our reports deliver fact-based news of research and discoveries from around the world.)